论文信息 - Bortezomib-thalidomide-dexamethasone (VTD) is superior to bortezomib-cyclophosphamide-dexamethasone (VCD) as induction therapy prior to autologous stem cell transplantation in multiple myeloma - 字舞流文

Bortezomib-thalidomide-dexamethasone (VTD) is superior to bortezomib-cyclophosphamide-dexamethasone (VCD) as induction therapy prior to autologous stem cell transplantation in multiple myeloma

A. Palumbo | P. Sonneveld | E. Zamagni | F. Raimondo | V. Montefusco | A. Palumbo | M. Petrucci | F. Patriarca | M. Cavo | P. Tacchetti | A. Brioli | G. Marzocchi | M. Galli | L. Pantani | B. Gamberi | A. Pezzi | Maria Teresa Petrucci | Angelo Pezzi